Ouster Q4 2025 slides: revenue doubles, margins expand to 60%
Dave Q4 2025 slides: revenue surges 62%, EBITDA margin hits 45%
Earnings call transcript: Asana Q4 2026 earnings beat estimates, stock fluctuates
Form 144 Madrigal Pharmaceuticals For: 2 March
Newsletter
Subscribe to get the latest news, offers and special announcements.


